M Bower

Summary

Country: UK

Publications

  1. ncbi Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London, UK
    AIDS 13:2105-11. 1999
  2. ncbi EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients
    M Bower
    Medical Oncology Unit, Charing Cross Hospital, London, United Kingdom
    J Clin Oncol 15:2636-43. 1997
  3. ncbi Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London, U K
    Eur J Cancer 35:601-4. 1999
  4. ncbi Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people
    J Stebbing
    St Stephen s Centre, Chelsea and Westminster Hospital, London, UK
    Postgrad Med J 81:586-8. 2005
  5. ncbi Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone
    R Jones
    Department of HIV and GU Medicine, The Chelsea and Westminster Hospital, London, UK
    HIV Med 6:396-402. 2005
  6. ncbi Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy
    C Palmieri
    Department of Medical Oncology, The Chelsea and Westminster Hospital, London, UK
    HIV Med 7:291-3. 2006
  7. ncbi Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London SW10 9NH, UK
    J Clin Oncol 23:5224-8. 2005
  8. ncbi The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily
    M Y Tung
    St Stephens Centre, Chelsea and Westminster Hospital, London, UK
    HIV Med 6:151-4. 2005
  9. ncbi Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy
    G V Matthews
    Chelsea and Westminster Hospital, London, U K
    J Acquir Immune Defic Syndr 24:310-5. 2000
  10. ncbi The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease
    J Stebbing
    Department of Oncology, Imperial College School of Medicine, Chelsea and Westminster Hospital, London UK
    Clin Exp Immunol 154:399-405. 2008

Collaborators

Detail Information

Publications53

  1. ncbi Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London, UK
    AIDS 13:2105-11. 1999
    ..To evaluate the impact of highly active antiretroviral therapy (HAART) on Kaposi's sarcoma...
  2. ncbi EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients
    M Bower
    Medical Oncology Unit, Charing Cross Hospital, London, United Kingdom
    J Clin Oncol 15:2636-43. 1997
    ....
  3. ncbi Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London, U K
    Eur J Cancer 35:601-4. 1999
    ..Recent improvements in outcome have been reported with systemic chemotherapy in HIV-PCNSL and may influence the need for earlier definitive diagnosis in the future...
  4. ncbi Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people
    J Stebbing
    St Stephen s Centre, Chelsea and Westminster Hospital, London, UK
    Postgrad Med J 81:586-8. 2005
    ..This study assessed the utility of the total lymphocyte count (TLC) in place of the CD4 count to predict the development of AIDS defining opportunistic infections (ADOI)...
  5. ncbi Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone
    R Jones
    Department of HIV and GU Medicine, The Chelsea and Westminster Hospital, London, UK
    HIV Med 6:396-402. 2005
    ..Metabolic abnormalities associated with antiretrovirals and cumulative exposure to combination antiretroviral therapy, including dyslipidaemia and insulin resistance, have been linked to an increased risk of myocardial infarction...
  6. ncbi Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy
    C Palmieri
    Department of Medical Oncology, The Chelsea and Westminster Hospital, London, UK
    HIV Med 7:291-3. 2006
    ..0001). CONCLUSION: PKS remains an ominous diagnosis in the era of HAART, with a median survival of just 1.6 years...
  7. ncbi Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London SW10 9NH, UK
    J Clin Oncol 23:5224-8. 2005
    ..This clinical response, known as the immune reconstitution inflammatory syndrome (IRIS), occurs secondary to an immune response against previously diagnosed pathogens...
  8. ncbi The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily
    M Y Tung
    St Stephens Centre, Chelsea and Westminster Hospital, London, UK
    HIV Med 6:151-4. 2005
    ..Low-dose ddI 250 mg once daily plus TDF as part of antiretroviral therapy was effective...
  9. ncbi Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy
    G V Matthews
    Chelsea and Westminster Hospital, London, U K
    J Acquir Immune Defic Syndr 24:310-5. 2000
    ..In conclusion, no differences were observed between choice of drug or combination on cholesterol or triglyceride values during therapy. Older individuals may be more likely to have elevated cholesterol values...
  10. ncbi The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease
    J Stebbing
    Department of Oncology, Imperial College School of Medicine, Chelsea and Westminster Hospital, London UK
    Clin Exp Immunol 154:399-405. 2008
    ..Systemic activation of cytokines was limited, suggesting that immunosuppressive therapy with steroids is not indicated in HHV-8-driven HPS...
  11. ncbi Outcome of patients with HIV-related germ cell tumours: a case-control study
    T Powles
    Department of Oncology, Chelsea and Westminster Hospital, Fulham Road, London SW10 9NH, UK
    Br J Cancer 90:1526-30. 2004
    ..78). The overall survival has not improved since the introduction of highly active antiretroviral therapy (log rank P=0.4). Thus, HIV-related GCT is not more aggressive than GCT in the general population...
  12. ncbi A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts
    L Waters
    St Stephen s Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    J Antimicrob Chemother 54:503-7. 2004
    ..To compare the immunological response to highly active antiretroviral therapy (HAART) in treatment-naive patients with a baseline CD4 count of <200 cells/mm(3)...
  13. ncbi Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality
    J Stebbing
    Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    Clin Exp Immunol 145:271-6. 2006
    ..001). Effective HAART-induced maintenance of the adaptive immune system (CD4, CD8 and CD19 counts) protects from HIV-related mortality...
  14. ncbi A single centre cohort experience with a new once daily antiretroviral drug
    J Stebbing
    Department of HIV Medicine, Chelsea and Westminster Hospital, London, UK
    Postgrad Med J 82:343-6. 2006
    ..CONCLUSIONS: These data should provide reassurance for clinicians wishing to introduce a new antiretroviral into an established cohort...
  15. ncbi The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease
    T Powles
    Department of Medical Oncology, Barts and the London Medical School, London, UK
    Ann Oncol 20:775-9. 2009
    ..In HIV cohorts with access to highly active antiretroviral therapy (HAART), the incidence of Kaposi's sarcoma (KS) is falling; however, the incidence of multicentric Castleman's disease (MCD) in HIV has not previously been described...
  16. ncbi Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus
    T Powles
    Department of Oncology, Chelsea and Westminster Hospital, London, UK
    J Laryngol Otol 118:207-12. 2004
    ..All but one of the patients died of cancer with a median survival of 28 months. Head and neck cancer occurs more frequently in HIV. It is an aggressive disease and EBV may play a role in its pathogenesis...
  17. ncbi A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
    T Powles
    Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Hammersmith Hospitals Campus of Imperial College London, London, UK
    Br J Cancer 96:732-7. 2007
    ..01)). The outcome of patients with relapsed GTN is good. However, patients with primary chemo-refractory disease do poorly and novel therapies are required for this group of patients...
  18. ncbi Multicenter study of human immunodeficiency virus-related germ cell tumors
    T Powles
    Chelsea and Westminster Hospital, London, United Kingdom
    J Clin Oncol 21:1922-7. 2003
    ..After a median follow-up of 4.6 years, 9% of the patients died from GCT. Most of the mortality relates to HIV infection...
  19. ncbi Outcome in AIDS-related systemic non-Hodgkin lymphoma and leptomeningeal disease is not predicted by a CT brain scan
    C L Davies
    Department of Oncology, Imperial College School of Science, Medicine and Technology, Chelsea and Westminster Hospital, London, United Kingdom
    AJNR Am J Neuroradiol 28:1988-90. 2007
    ..We investigated the utility of brain CT in determining the outcome of leptomeningeal disease, despite MR imaging being the gold standard...
  20. ncbi Weekly alternating combination chemotherapy for good prognosis AIDS-related lymphoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, 369 Fulham Road, London, UK
    Eur J Cancer 36:363-7. 2000
    ..For selected patients with good prognosis ARL 12 weeks BEMOP/CA therapy produces good overall survival at 2 years...
  21. ncbi Anal intraepithelial neoplasia in HIV positive people
    F Martin
    Department of Oncology, Chelsea and Westminster Hospital, Fulham Road, London SW10 9NH, UK
    Sex Transm Infect 77:327-31. 2001
    ..However, routine anal cytological screening will surely have to await an effective proved intervention for AIN and this would seem to be a pressing clinical goal...
  22. ncbi Placental site trophoblastic tumor: molecular analysis and clinical experience
    M Bower
    Medical Oncology Unit, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, United Kingdom
    Clin Cancer Res 2:897-902. 1996
    ..Five were diploid biparental tumors following term pregnancies, and three were androgenetic tumors following monospermic complete hydatidiform moles...
  23. ncbi Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals
    G Rosignoli
    Department of Immunology, Imperial College London, Chelsea and Westminster Hospital, London, UK
    Clin Exp Immunol 157:90-7. 2009
    ....
  24. ncbi Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression
    M Alfa-Wali
    Department of Surgery and Cancer, Imperial College London, and Department of Clinical Oncology, Royal Marsden Hospital, London, UK
    Ann Oncol 23:141-7. 2012
    ..We present the clinical features and treatment outcomes of anal cancer in 60 HIV-positive patients over a 20-year period...
  25. ncbi AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy
    C Palmieri
    Department of Oncology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    QJM 99:811-26. 2006
    ..In the era of HAART, the goal of therapy for these patients is now complete remission rather than palliation...
  26. ncbi Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era
    S H Allen
    Department of Microbiology, Chelsea and Westminster Hospital, London
    Postgrad Med J 79:691-4. 2003
    ..These findings have implications for the treatment of individuals presenting with serious infections in which antibiotic therapy needs to be instituted before identification and sensitivities are known...
  27. ncbi An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals
    M Nelson
    Chelsea and Westminster Hospital, London, UK
    AIDS 17:F7-10. 2003
    ..INTERPRETATION: These results indicate that 52 weeks of tenofovir in addition to antiretroviral therapy is active against HBV, and it appears to overcome lamivudine resistance...
  28. ncbi The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection
    J Wang
    Department of Oncology and HIV Medicine, Chelsea and Westminster Hospital, London, UK
    HIV Med 8:306-11. 2007
    ..However, EBV may also be detected in the CSF of patients without PCL, and here the significance is uncertain...
  29. ncbi Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations
    J Stebbing
    Departments of Oncology and HIV Medicine, Chelsea and Westminster Hospital, London, UK
    Ann Oncol 14:1660-6. 2003
    ..Overall, clinical response in KS correlates poorly with known angiogenic cytokines...
  30. ncbi Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?
    T Powles
    Department of Oncology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    Br J Cancer 89:457-9. 2003
    ..This suggests that the survival of patients with HIV-related NSCLC may have improved since the introduction of HAART, and this may be due to a decrease in HIV-related deaths...
  31. ncbi The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors
    J Stebbing
    Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Chelsea and Westminster Hospital, London, UK
    Clin Exp Immunol 138:312-6. 2004
    ....
  32. ncbi HIV-related lung cancer -- a growing concern?
    T Powles
    Department of Oncology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    Int J STD AIDS 14:647-51. 2003
    ..Thus lung cancer and possibly other non-AIDS-defining malignancies may become an increasingly frequent problem whose prognosis has not improved in the era of HAART...
  33. ncbi Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre
    K Fife
    Medical Oncology Unit, Charing Cross Hospital, London, UK
    Int J STD AIDS 9:751-5. 1998
    ..This preliminary study demonstrates that thalidomide has activity in the treatment of AIDS-KS and that clinical response is associated with a reduction of HHV8 DNA titre in peripheral blood...
  34. ncbi CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK
    Mark Bower
    Research Department of Infection and Population Health, Division of Population Health, UCL Medical School, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK
    Haematologica 94:875-80. 2009
    ..Earlier highly active anti-retroviral therapy initiation and wider access to HIV testing is advocated to reduce the risk of systemic non-Hodgkin's lymphoma...
  35. ncbi The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
    T Powles
    Charing Cross Gestational Trophoblastic Centre, London, UK
    Br J Cancer 95:1145-7. 2006
    ..The interval between antecedent pregnancy and diagnosis in high-risk GTT is of prognostic significance. This gives some insight into the pathogenesis of the disease...
  36. ncbi Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function
    C T Burton
    Department of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, UK
    Clin Exp Immunol 166:191-200. 2011
    ..We propose that before immunotherapeutic manipulation of T(regs) is considered, the immunoregulatory profile and distribution kinetics of this population in chronic HIV-1 infection must be elucidated fully...
  37. ncbi Immune reconstitution inflammatory syndrome mimicking relapse of AIDS related lymphoma in patients with HIV 1 infection
    T Powles
    Departments of Oncology and HIV Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    Leuk Lymphoma 44:1417-9. 2003
    ..We present three cases of IRIS following a diagnosis of AIDS related non-Hodgkin's lymphoma that resembled lymphoma relapse...
  38. ncbi Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast
    C Harper Wynne
    Department of Medical Oncology, Imperial College School of Medicine, Charing Cross Hospital, London, UK
    Br J Cancer 81:316-22. 1999
    ....
  39. ncbi Current issues in the biology of AIDS-related lymphoma
    M Bower
    Department of Oncology, Chelsea and Westminster Hospital, London, UK
    HIV Med 2:141-5. 2001
    ..These topics are covered in this article and their potential application to the clinical management of AIDS-related lymphomas are discussed...
  40. ncbi Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
    A P Doherty
    Department of Urology, Charing Cross Hospital, Fulham Palace Road, London
    Br J Cancer 83:1432-6. 2000
    ..Thus, sensitive prostate-specific antigen assays offer accurate prognostic information and expedite decision-making regarding the use of salvage prostate-bed radiotherapy or hormone therapy...
  41. ncbi High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors
    M P Lyttelton
    Department of Haematology, Imperial College School of Medicine, Hammersmith Hospitals NHS Trust, London, UK
    Br J Cancer 77:1672-6. 1998
    ....
  42. ncbi The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic
    P A Fox
    Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
    Sex Transm Infect 81:142-6. 2005
    ..Previous studies have reached differing conclusions about the utility of anal cytology as a screening tool for anal intraepithelial neoplasia (AIN). There is a need also to establish whether HPV typing offers a useful adjunct to screening...
  43. ncbi The current role of surgery in the management of residual disease
    T J Christmas
    Department of Urology, Imperial College School of Medicine, Charing Cross Hospital, London, UK
    Curr Opin Urol 9:439-42. 1999
    ..Retroperitoneal lymph node dissection also appears to be worthwhile in chemotherapy-resistant disease ('desperation retroperitoneal lymph node dissection'), although the relapse rate is higher in this group...
  44. ncbi The changing role of radiotherapy in AIDS-related malignancies
    J Lukawska
    Department of Oncology, Chelsea and Westminster Hospital, London SW10 9NH, UK
    Clin Oncol (R Coll Radiol) 15:2-6. 2003
    ..Chemoradiotherapy remains the mainstay of management for anal cancer, has a central role in cervical cancer and non-AIDS defining malignancies in this population...
  45. ncbi Imaging features of multicentric Castleman's disease in HIV infection
    J C Hillier
    Clinical Radiology, Chelsea and Westminster Hospital, London, UK
    Clin Radiol 59:596-601. 2004
    ..To describe the computed tomography (CT) features of human immunodeficiency virus (HIV)-associated Castleman's disease...
  46. ncbi HIV-related testicular cancer
    T Powles
    Department of HIV, Chelsea and Westminster Hospital, London SW10 9NH, UK
    Int J STD AIDS 14:24-7. 2003
  47. ncbi A questionnaire survey of stress and bullying in doctors undertaking research
    J Stebbing
    Chelsea and Westminster Hospital, London, UK
    Postgrad Med J 80:93-6. 2004
    ..Research is an increasingly important aspect of higher medical training for many doctors. Studies investigating sources of stress, isolation, and workplace bullying have not previously sought information in this setting...
  48. ncbi Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
    S Balesaria
    Department of Cancer Medicine, Imperial College School of Medicine, Charing Cross Hospital, London, UK
    Br J Cancer 81:1371-7. 1999
    ..We conclude that LOH for chromosome 10 is an independent, adverse prognostic variable in high-grade glioma...
  49. ncbi Phase I study of TNFalpha AutoVaccIne in patients with metastatic cancer
    A M Waterston
    Department of Cancer Medicine, Faculty of Medicine, Imperial College School of Medicine, London, W12 0HS, UK
    Cancer Immunol Immunother 54:848-57. 2005
    ..However, since the antibodies were only able to cross-react with partly denatured TNFalpha, evaluation of safety and tumour responses to the TNFalpha vaccine was compromised...
  50. ncbi Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir
    N Kumar
    Department of HIV Medicine, Chelsea and Westminster Hospital, London, UK
    Int J STD AIDS 23:59-60. 2012
    ..This emphasizes that while monitoring for adverse effects is recommended, physicians must consider all alternative causes for biochemical abnormalities prior to discontinuing tenofovir and delaying appropriate management...
  51. ncbi Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients
    F Amen
    Department of Histopathology, Hammersmith Hospital and Imperial College, London, UK
    Histopathology 51:70-9. 2007
    ..To validate and improve the existing algorithm (proposed by Hans et al.) to classify diffuse large B-cell lymphoma (DLBCL)...
  52. ncbi DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
    S Lee
    Laboratory of Cancer Genetics and Epigenetics, Breakthrough Breast Cancer, Institute of Cancer Research, Fulham Road, London, UK
    Br J Cancer 103:265-74. 2010
    ..Little is known of the expression, regulation or function of the DUSPs in human neoplasia...
  53. ncbi Clostridium difficile infection, hospital geography and time-space clustering
    P B Kroker
    Department of Medicine, Day Unit, Chelsea and Westminster Hospital, Fulham Road, London SW10 9NH, UK
    QJM 94:223-5. 2001
    ..The results support the importance of infection control measures in the prevention of C. difficile-related disease...